LAG3 and cancer: Immune checkpoints Therapy are monoclonal antibodies targeting critical regulators of the immune system like PD-1/PDL-1, CTLA4, LAG-3 that revigorate exhausted T-cells and prolong their activity. Some cancer cells also exploit this regulation to protect themselves, but this cancer-associated inhibition may be canceled with ICTs.